OncoDecipher

Identifying Silent Mutations for Cancer Classification and Prognosis

Startup

OncoDecipher is a Ra'anana-based startup in the Health Tech & Life Sciences sector, established in 2021. Identifying Silent Mutations for Cancer Classification and Prognosis. OncoDecipher was founded by Tamir Tuller. Key investors include Sanara Ventures. The company has 1-10 employees. Core technologies: Platforms & Interfaces, Web, Artificial Intelligence, Machine Learning.

The company follows a B2B business model. Product stage: R&D.

1
Rounds
1
Investors
1
Team
2021
Founded
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & ScreeningPlatforms & InterfacesWebArtificial IntelligenceMachine Learning
At a Glance
Investors
Founders
In the News

2 articles covered by sources including www.jpost.com, www.nature.com.

www.jpost.com · Sep 1, 2021
https://www.jpost.com/health-and-wellness/silent-mutations-can-predict-the-development-of-cancer-study-678299?fbclid=IwAR0DVQM0F_U3xJW9taReGbRzaydXsECch0YaRim4n6fLz47g1EzWMrGJQVo
Read article ↗
Frequently Asked Questions
What does OncoDecipher do?

OncoDecipher is developing a computational biology platform to identify silent mutations and improve pharmaceutical companies ability to identify patients who will benefit from a given treatment.

Who founded OncoDecipher?

OncoDecipher was founded in 2021 by Tamir Tuller (Founder).

What sector is OncoDecipher in?

OncoDecipher operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Test Diagnostics & Screening, with core technologies in Platforms & Interfaces, Web, Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

Where is OncoDecipher located?

OncoDecipher is based in Zarhin Street 13, Ra'anana, Israel, Center District.

View Full Profile Classic View